| abstract |
FIELD: biotechnology. n SUBSTANCE: described is a group of inventions including an adenovirus system for treating cancer, an anti-cancer composition including the above adenovirus system, and a composition for enhancing the anti-tumour immunity including the above adenovirus system. In one of the implementations, the adenovirus system contains a gene encoding interleukin-12 (IL-12); and a gene expressing an oligonucleotide complementary to C-met (Met tyrosine kinase) mRNA and inhibits C-met expression. n EFFECT: invention expands the range of anticancer products. n 15 cl, 22 dwg, 2 tbl, 16 ex |